| Q1 FY27 | Jul 31, 2026 | 9 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY26 | Apr 30, 2026 | 12 | +300.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY26 | Jan 31, 2026 | 12 | +71.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY26 | Oct 31, 2025 | 8 | +33.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY26 | Jul 31, 2025 | 9 | +28.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY25 | Apr 30, 2025 | 3 | -57.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY25 | Jan 31, 2025 | 7 | +133.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY25 | Oct 31, 2024 | 6 | -25.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY25 | Jul 31, 2024 | 7 | +16.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY24 | Apr 30, 2024 | 7 | +40.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY24 | Jan 31, 2024 | 3 | -50.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY24 | Oct 31, 2023 | 8 | +166.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY24 | Jul 31, 2023 | 6 | +100.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY23 | Apr 30, 2023 | 5 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY23 | Jan 31, 2023 | 6 | -25.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY23 | Oct 31, 2022 | 3 | -50.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY23 | Jul 31, 2022 | 3 | -75.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY22 | Apr 30, 2022 | 5 | +150.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY22 | Jan 31, 2022 | 8 | +14.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY22 | Oct 31, 2021 | 6 | -14.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY22 | Jul 31, 2021 | 12 | +9.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY21 | Apr 30, 2021 | 2 | -75.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY21 | Jan 31, 2021 | 7 | +40.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY21 | Oct 31, 2020 | 7 | -30.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY21 | Jul 31, 2020 | 11 | +10.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY20 | Apr 30, 2020 | 8 | -27.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY20 | Jan 31, 2020 | 5 | -44.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY20 | Oct 31, 2019 | 10 | +11.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY20 | Jul 31, 2019 | 10 | +66.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY19 | Apr 30, 2019 | 11 | +37.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY19 | Jan 31, 2019 | 9 | +50.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY19 | Oct 31, 2018 | 9 | +12.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY19 | Jul 31, 2018 | 6 | -57.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY18 | Apr 30, 2018 | 8 | -52.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY18 | Jan 31, 2018 | 6 | -25.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY18 | Oct 31, 2017 | 8 | -38.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY18 | Jul 31, 2017 | 14 | +180.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY17 | Apr 30, 2017 | 17 | +54.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY17 | Jan 31, 2017 | 8 | -20.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY17 | Oct 31, 2016 | 13 | +18.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY17 | Jul 31, 2016 | 5 | -61.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY16 | Apr 30, 2016 | 11 | -35.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY16 | Jan 31, 2016 | 10 | +11.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY16 | Oct 31, 2015 | 11 | -8.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY16 | Jul 31, 2015 | 13 | +8.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY15 | Apr 30, 2015 | 17 | +54.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY15 | Jan 31, 2015 | 9 | +800.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY15 | Oct 31, 2014 | 12 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY15 | Jul 31, 2014 | 12 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY14 | Apr 30, 2014 | 11 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY14 | Jan 31, 2014 | 1 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|